Ora Inc. , the world's leading clinical research organization developing eye care medicines and devices, today announced a collaboration with the North West London Clinical Trials Alliance a coalition of clinical trials teams working to improve access to and quality of clinical research in the London area.

This strategic cooperation comes at a crucial time when the UK Government is placing a particular emphasis on innovative collaboration and encouraging increased cross-sectoral collaboration. The collaboration between Ora and the NWL Clinical Trials Alliance directly supports this initiative, which brings together academia, industry and the UK National Health Service, the NHS, to provide better solutions that address gaps in patient access to innovative therapies.

"Ora and the NWL Clinical Trials Alliance share a common goal: to improve access and quality of clinical research in Europe ," said Stuart Abelson, CEO of Ora. “Ora's undisputed leadership in eye care research, combined with the reach and relationships that the NWL Clinical Trials Alliance has built, will provide our sponsors with a higher level of confidence in conducting early and late stage European research studies ."

Ora and the NWL Clinical Trials Alliance offer the following services to sponsors planning or considering conducting trials in Europe:

• Comprehensive analysis of the country and site selection along with open feedback based on open, honest communication with the study centers
• Access to a diverse group of study participants interested in new treatment options
• Operational excellence delivered by experienced ophthalmology professionals committed to delivering trials quickly, efficiently, with high quality and cost-effectively

“We are honored to be collaborating with a world-renowned leader in eye care research. The cooperation with Ora will improve treatment outcomes for previously underrepresented patient groups. In addition, this also offers the opportunity to break new, innovative ground in order to improve access to clinical trials for all patients. Europe has the ability to bring medicines to market faster while helping to build a robust, sustainable environment for clinical research outside of the US,” said Dr. Suki Balendra, Director of the NWL Clinical Trials Alliance.

About Ora Inc.

Ora is the world's leading full-service eye care drug and device development company with offices in North America, South America, Europe, Australia and Asia. We're proud to have helped our customers achieve more than 82 product approvals for over 45 years. We support a wide range of companies, from start-ups to global pharmaceutical and device manufacturers, in their goal of taking their new products efficiently from conception to market. Ora's preclinical and clinical models, unique methodologies and global regulatory strategies have been proven in thousands of projects around the world. We have the largest, most experienced team in the world, made up of experts in ophthalmology, of research and development and management to maximize the value of new product initiatives. For more information, seewww.oraclinical.com . Also follow us on Facebook and LinkedIn

Ora® and the Ora logo are registered trademarks of Ora Inc.

About the North West London Clinical Trials Alliance

The North West London Clinical Trials Alliance is dedicated to conducting commercial and non-commercial sponsored clinical trials, utilizing existing as well as purpose-built facilities to successfully conduct both early and late stage research projects. The aim of the alliance is to increase regional capacity to conduct commercial clinical research projects, simplify and accelerate patient access to clinical trials and provide patients with early access to innovative treatment options and therapies not yet available in the UK's NHS are generally available. We achieve this through collaborations, using our knowledge of the needs and priorities of life science companies and our strong regional team spirit to achieve harmonized workflows across centers. The Ophthalmology Unit of the London North West University Healthcare NHS Trust, which is part of the North West London Clinical Trials Alliance, is nationally recognized as one of the UK's leading providers of commercial trials. She is committed to expanding access to novel, innovative therapies for diverse populations in the UK, so that better outcomes can be achieved for them. The Ophthalmology Unit of the London North West University Healthcare NHS Trust, which is part of the North West London Clinical Trials Alliance, is nationally recognized as one of the UK's leading providers of commercial trials. She is committed to expanding access to novel, innovative therapies for diverse populations in the UK, so that better outcomes can be achieved for them. The Ophthalmology Unit of the London North West University Healthcare NHS Trust, which is part of the North West London Clinical Trials Alliance, is nationally recognized as one of the UK's leading providers of commercial trials. She is committed to expanding access to novel, innovative therapies for diverse populations in the UK, so that better outcomes can be achieved for them.

The source language in which the original text is published is the official and authorized version. Translations will be included for a better understanding. Only the language version that was originally published is legally valid. Therefore, compare translations with the original language version of the publication.

Contacts
Media Contact:
Claire Russell
crussell@oraclinical.com
Tel. +1 (919) 597-9029

 

Source:businesswire.com

Report Abuse